(RTTNews) – HBM Holdings Restricted or Harbour BioMed (HBMHF) Wednesday stated that Youchen Chen has been appointed as the brand new Chief Monetary Officer. Chen might be based mostly in Shanghai and Hong Kong SAR, and report on to Founder, Chairman, and CEO, Jingsong Wang.
On the Hong Kong Inventory Trade, the biopharmaceutical firm’s inventory is buying and selling up 11 p.c at HK$ 6.600.
Harbour BioMed stated that in his new position, Chen will lead the corporate into its subsequent stage of strategic progress.
He joined the corporate in 2023, heading essential positions throughout departments like Investor Relations, Company Growth, Enterprise Growth, and Finance.
Previous to becoming a member of Harbour BioMed, Chen served as Chief Monetary Officer at a clinical-stage radiopharmaceutical startup. He had earlier labored as Vice President at Credit score Suisse China Funding Banking and Capital Market staff, advising healthcare and know-how corporations in Higher China on strategic and financing transactions, the corporate stated.
Commenting on the appointment, Jingsong Wang, stated, “YC has introduced a powerful strategic mindset and deep monetary experience to Harbour BioMed. His skill to steer cross-functional initiatives and drive worth creation has made a major impression throughout the group. I am assured that in his new position as Chief Monetary Officer, he’ll proceed to strengthen our monetary basis and assist our long-term progress.”
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
